Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,530,908 papers from all fields of science
Search
Sign In
Create Free Account
hirsutanone
Known as:
1,7-di-(3',4'-dihydroxyphenyl)-4-hepten-3-one
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Diarylheptanoids
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Cytotoxic activity of hirsutanone, a diarylheptanoid isolated from Alnus glutinosa leaves.
A. J. León-González
,
N. Acero
,
D. Muñoz-Mingarro
,
Miguel López-Lázaro
,
C. Martín-Cordero
Phytomedicine
2014
Corpus ID: 23455107
2012
2012
Antibacterial activity of bark of Alnus pendula against methicillin-resistant Staphylococcus aureus.
J. Choi
,
M. Lee
,
+10 authors
D. Kwon
European Review for Medical and Pharmacological…
2012
Corpus ID: 35945576
BACKGROUND AND OBJECTIVES Methicillin-resistant Staphylococcus aureus (MRSA) infections are a rapidly growing health problem…
Expand
2011
2011
Quantitative Analysis and Preformulation of Extracts from Alnus Japonica
Jong-Suep Baek
,
Hee‐Chul Kang
,
+6 authors
C. Cho
2011
Corpus ID: 53998364
ABSTRACT − Alnus japonica has been known to exert antioxidative, anti-inflammatory, anti-cancer and immune responseinhibitory…
Expand
2005
2005
Antioxidant Effects of Diarylheptanoid Derivatives from Alnus japonica on Human LDL Oxidation
Woo Lee1 , 3
,
Ju-Ryoung Kim1 , 3
,
Kyung-Ran Im1
,
Kyung-Hyun Cho1
,
Dai-Eun Sok2
,
Tae-Sook Jeong1
Planta Medica
2005
Corpus ID: 34386061
1 2 Alnus japonica 1 2 1 2 1 : 2 : 1 : 2 : 1 : 2 : 1 : 2 :
2001
2001
A cytotoxic diarylheptanoid from Viscum cruciatum.
C. Martín-Cordero
,
Miguel López-Lázaro
,
Marı́a Angeles Agudo
,
Eduardo Navarro
,
J. Trujillo
,
M. Ayuso
Phytochemistry
2001
Corpus ID: 21385818
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required